Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chong

Showing results (321-330 of 348) with videos related to

Pageof 35
Sort By:
Molecular Phylogenetics and Evolution|June 29, 2014
A hybrid phylogenetic-phylogenomic approach for species tree estimation in African Agama lizards with applications to biogeography, character evolution, and diversificationAdam D Leaché, Philipp Wagner, Charles W Linkem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaStephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Microbiology Resource Announcements|October 17, 2022
Genome Sequence of <i>Arthrobacter</i> Phage NathanVaagRebecca A Chong, Charlie M Cosse, Viviana Gaytan, et al.
Plos One|February 1, 2018
Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in miceStefan Just, Bertrand L Chenard, Angelo Ceci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Blood Advances|August 18, 2023
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohortJackson T Bowers, Jacob Anna, Steven M Bair, et al.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal diseaseBrian Leei Lin, Damian Matera, Julia F Doerner, et al.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Pageof 35

Showing results (321-330 of 348) with videos related to

Sort By:
Pageof 35
Molecular Phylogenetics and Evolution|June 29, 2014
A hybrid phylogenetic-phylogenomic approach for species tree estimation in African Agama lizards with applications to biogeography, character evolution, and diversificationAdam D Leaché, Philipp Wagner, Charles W Linkem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaStephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Microbiology Resource Announcements|October 17, 2022
Genome Sequence of <i>Arthrobacter</i> Phage NathanVaagRebecca A Chong, Charlie M Cosse, Viviana Gaytan, et al.
Plos One|February 1, 2018
Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in miceStefan Just, Bertrand L Chenard, Angelo Ceci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2022
Bendamustine is safe and effective for lymphodepletion before tisagenlecleucel in patients with refractory or relapsed large B-cell lymphomasG Ghilardi, E A Chong, J Svoboda, et al.
Blood Advances|August 18, 2023
Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohortJackson T Bowers, Jacob Anna, Steven M Bair, et al.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
NEJM Evidence|May 22, 2024
CAR T-Cell Immunotherapy in Minority Patients with LymphomaGuido Ghilardi, Staci Williamson, Raymone Pajarillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2019
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal diseaseBrian Leei Lin, Damian Matera, Julia F Doerner, et al.
Blood Advances|December 19, 2023
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Luca Paruzzo, Jakub Svoboda, et al.
Pageof 35